![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:AGGF1-RAF1 (FusionGDB2 ID:HG55109TG5894) |
Fusion Gene Summary for AGGF1-RAF1 |
![]() |
Fusion gene information | Fusion gene name: AGGF1-RAF1 | Fusion gene ID: hg55109tg5894 | Hgene | Tgene | Gene symbol | AGGF1 | RAF1 | Gene ID | 55109 | 5894 |
Gene name | angiogenic factor with G-patch and FHA domains 1 | Raf-1 proto-oncogene, serine/threonine kinase | |
Synonyms | GPATC7|GPATCH7|HSU84971|HUS84971|VG5Q | CMD1NN|CRAF|NS5|Raf-1|c-Raf | |
Cytomap | ('AGGF1')('RAF1') 5q13.3 | 3p25.2 | |
Type of gene | protein-coding | protein-coding | |
Description | angiogenic factor with G patch and FHA domains 1G patch domain-containing protein 7angiogenic factor VG5Qvasculogenesis gene on 5q protein | RAF proto-oncogene serine/threonine-protein kinaseC-Raf proto-oncogene, serine/threonine kinaseOncogene RAF1proto-oncogene c-RAFraf proto-oncogene serine/threonine protein kinasev-raf-1 murine leukemia viral oncogene homolog 1v-raf-1 murine leukemia | |
Modification date | 20200313 | 20200327 | |
UniProtAcc | . | P04049 | |
Ensembl transtripts involved in fusion gene | ENST00000312916, ENST00000503538, ENST00000506806, | ENST00000312916, ENST00000503538, ENST00000506806, | |
Fusion gene scores | * DoF score | 3 X 2 X 3=18 | 19 X 16 X 7=2128 |
# samples | 3 | 18 | |
** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(18/2128*10)=-3.56342933917152 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: AGGF1 [Title/Abstract] AND RAF1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | AGGF1(76335544)-RAF1(12641914), # samples:5 | ||
Anticipated loss of major functional domain due to fusion event. | AGGF1-RAF1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. AGGF1-RAF1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. AGGF1-RAF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. AGGF1-RAF1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | AGGF1 | GO:0001938 | positive regulation of endothelial cell proliferation | 14961121 |
Hgene | AGGF1 | GO:0007155 | cell adhesion | 14961121 |
Hgene | AGGF1 | GO:0045766 | positive regulation of angiogenesis | 14961121 |
Tgene | RAF1 | GO:0000186 | activation of MAPKK activity | 10644344 |
Tgene | RAF1 | GO:0007190 | activation of adenylate cyclase activity | 15385642 |
Tgene | RAF1 | GO:0008285 | negative regulation of cell proliferation | 9765203 |
Tgene | RAF1 | GO:0031333 | negative regulation of protein complex assembly | 19667065 |
Tgene | RAF1 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 19667065 |
Tgene | RAF1 | GO:0043066 | negative regulation of apoptotic process | 19667065 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PRAD | TCGA-CH-5737-01A | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
ChimerDB4 | THCA | TCGA-BJ-A2N7-01A | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
ChimerDB4 | THCA | TCGA-DJ-A2Q4-01A | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
ChimerDB4 | THCA | TCGA-EM-A1CS-01A | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
Top |
Fusion Gene ORF analysis for AGGF1-RAF1 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000312916 | ENST00000251849 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
In-frame | ENST00000312916 | ENST00000442415 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
In-frame | ENST00000312916 | ENST00000534997 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
In-frame | ENST00000312916 | ENST00000542177 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
intron-3CDS | ENST00000503538 | ENST00000251849 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
intron-3CDS | ENST00000503538 | ENST00000442415 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
intron-3CDS | ENST00000503538 | ENST00000534997 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
intron-3CDS | ENST00000503538 | ENST00000542177 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
intron-3CDS | ENST00000506806 | ENST00000251849 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
intron-3CDS | ENST00000506806 | ENST00000442415 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
intron-3CDS | ENST00000506806 | ENST00000534997 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
intron-3CDS | ENST00000506806 | ENST00000542177 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000312916 | AGGF1 | chr5 | 76335544 | + | ENST00000251849 | RAF1 | chr3 | 12641914 | - | 3278 | 1252 | 286 | 2364 | 692 |
ENST00000312916 | AGGF1 | chr5 | 76335544 | + | ENST00000442415 | RAF1 | chr3 | 12641914 | - | 3081 | 1252 | 286 | 2364 | 692 |
ENST00000312916 | AGGF1 | chr5 | 76335544 | + | ENST00000534997 | RAF1 | chr3 | 12641914 | - | 2612 | 1252 | 286 | 2364 | 692 |
ENST00000312916 | AGGF1 | chr5 | 76335544 | + | ENST00000542177 | RAF1 | chr3 | 12641914 | - | 2546 | 1252 | 286 | 2364 | 692 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000312916 | ENST00000251849 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - | 0.003556621 | 0.99644333 |
ENST00000312916 | ENST00000442415 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - | 0.005202861 | 0.99479717 |
ENST00000312916 | ENST00000534997 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - | 0.00489195 | 0.99510807 |
ENST00000312916 | ENST00000542177 | AGGF1 | chr5 | 76335544 | + | RAF1 | chr3 | 12641914 | - | 0.005396192 | 0.9946038 |
Top |
Fusion Genomic Features for AGGF1-RAF1 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
![]() |
![]() |
Top |
Fusion Protein Features for AGGF1-RAF1 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr5:76335544/chr3:12641914) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | RAF1 |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation. {ECO:0000269|PubMed:11427728, ECO:0000269|PubMed:11719507, ECO:0000269|PubMed:15385642, ECO:0000269|PubMed:15618521, ECO:0000269|PubMed:15849194, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:16924233, ECO:0000269|PubMed:9360956}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | AGGF1 | chr5:76335544 | chr3:12641914 | ENST00000312916 | + | 5 | 14 | 18_88 | 290 | 715.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | AGGF1 | chr5:76335544 | chr3:12641914 | ENST00000312916 | + | 5 | 14 | 12_15 | 290 | 715.0 | Compositional bias | Note=Poly-Pro |
Tgene | RAF1 | chr5:76335544 | chr3:12641914 | ENST00000251849 | 6 | 17 | 349_609 | 278 | 649.0 | Domain | Protein kinase | |
Tgene | RAF1 | chr5:76335544 | chr3:12641914 | ENST00000442415 | 7 | 18 | 349_609 | 298 | 669.0 | Domain | Protein kinase | |
Tgene | RAF1 | chr5:76335544 | chr3:12641914 | ENST00000251849 | 6 | 17 | 355_363 | 278 | 649.0 | Nucleotide binding | ATP | |
Tgene | RAF1 | chr5:76335544 | chr3:12641914 | ENST00000442415 | 7 | 18 | 355_363 | 298 | 669.0 | Nucleotide binding | ATP |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | AGGF1 | chr5:76335544 | chr3:12641914 | ENST00000506806 | + | 1 | 3 | 18_88 | 0 | 177.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | AGGF1 | chr5:76335544 | chr3:12641914 | ENST00000506806 | + | 1 | 3 | 12_15 | 0 | 177.0 | Compositional bias | Note=Poly-Pro |
Hgene | AGGF1 | chr5:76335544 | chr3:12641914 | ENST00000312916 | + | 5 | 14 | 434_487 | 290 | 715.0 | Domain | FHA |
Hgene | AGGF1 | chr5:76335544 | chr3:12641914 | ENST00000312916 | + | 5 | 14 | 619_665 | 290 | 715.0 | Domain | G-patch |
Hgene | AGGF1 | chr5:76335544 | chr3:12641914 | ENST00000506806 | + | 1 | 3 | 434_487 | 0 | 177.0 | Domain | FHA |
Hgene | AGGF1 | chr5:76335544 | chr3:12641914 | ENST00000506806 | + | 1 | 3 | 619_665 | 0 | 177.0 | Domain | G-patch |
Tgene | RAF1 | chr5:76335544 | chr3:12641914 | ENST00000251849 | 6 | 17 | 56_131 | 278 | 649.0 | Domain | RBD | |
Tgene | RAF1 | chr5:76335544 | chr3:12641914 | ENST00000442415 | 7 | 18 | 56_131 | 298 | 669.0 | Domain | RBD | |
Tgene | RAF1 | chr5:76335544 | chr3:12641914 | ENST00000251849 | 6 | 17 | 138_184 | 278 | 649.0 | Zinc finger | Phorbol-ester/DAG-type | |
Tgene | RAF1 | chr5:76335544 | chr3:12641914 | ENST00000442415 | 7 | 18 | 138_184 | 298 | 669.0 | Zinc finger | Phorbol-ester/DAG-type |
Top |
Fusion Gene Sequence for AGGF1-RAF1 |
![]() |
>2882_2882_1_AGGF1-RAF1_AGGF1_chr5_76335544_ENST00000312916_RAF1_chr3_12641914_ENST00000251849_length(transcript)=3278nt_BP=1252nt GGTCCCGCCTGCCGCTGGCGCCGTTGTTTCCGGCTCAACTGGGGAGCTGCTGGAGCTCTTCTGGCCTCTGGTTTTCCGACTGCTTATCCG ACGCTCCTCCCTCTGTCTCTGTAGCTGGAGAAGGTAGTTTCCAGGAAAGTTTTCCGGTTTGCAGGCCGCGCACATCGGGCAGGGGCCATC CTCGGTCCCCTTGCTCGTTGCTCGCAGCCCCGTTCGGCTACAAGTGAGTTTCAGGGCGTCATGGCCAGGGGCCACCGCGGCCAGCCGGGT GTGAGGCTGCCTTTCGCTGCCCGCGCGCTCCAGTGGTCTCTGGGTCCGCCGGCGTCCGTTTCGGCCTGAACGCAGCCCCTCCGCGGCGAC GAGCAGTCTCGCGCCGGAGCTCATGGCCTCGGAGGCGCCGTCCCCGCCGCGGTCGCCGCCGCCGCCCACCTCCCCCGAGCCTGAGCTGGC CCAGCTAAGGCGGAAGGTGGAGAAGTTGGAACGTGAACTGCGGAGCTGCAAGCGGCAGGTGCGGGAGATCGAGAAGCTGCTGCATCACAC AGAACGGCTGTACCAGAACGCAGAAAGCAACAACCAGGAGCTCCGCACGCAGGTGGAAGAACTCAGTAAAATACTCCAACGTGGGAGAAA TGAAGATAATAAAAAGTCTGATGTAGAAGTACAAACAGAGAACCATGCTCCTTGGTCAATCTCAGATTATTTTTATCAGACGTACTACAA TGACGTTAGTCTTCCAAATAAAGTGACTGAACTGTCAGATCAACAAGATCAAGCTATCGAAACTTCTATTTTGAATTCTAAAGACCATTT ACAAGTAGAAAATGATGCTTACCCTGGTACCGATAGAACAGAAAATGTTAAATATAGACAAGTGGACCATTTTGCCTCAAATTCACAGGA GCCAGCATCTGCATTAGCAACAGAAGATACCTCCTTAGAAGGCTCATCATTAGCTGAAAGTTTGAGAGCTGCAGCAGAAGCGGCTGTATC ACAGACTGGATTTAGTTATGATGAAAATACTGGACTGTATTTTGACCACAGCACTGGTTTCTATTATGATTCTGAAAATCAACTCTATTA TGATCCTTCCACTGGAATTTATTACTATTGTGATGTGGAAAGTGGTCGTTATCAGTTTCATTCTCGAGTAGATTTGCAACCTTATCCGAC TTCTAGCACAAAACAAAGTAAAGATAAAAAATTGAAGAAGAAAAGAAAAGATCCAGATTCTTCTGCAACAAATGAGGAAAAGGATGCAAT TCGAAGTCACAGCGAATCAGCCTCACCTTCAGCCCTGTCCAGTAGCCCCAACAATCTGAGCCCAACAGGCTGGTCACAGCCGAAAACCCC CGTGCCAGCACAAAGAGAGCGGGCACCAGTATCTGGGACCCAGGAGAAAAACAAAATTAGGCCTCGTGGACAGAGAGATTCAAGCTATTA TTGGGAAATAGAAGCCAGTGAAGTGATGCTGTCCACTCGGATTGGGTCAGGCTCTTTTGGAACTGTTTATAAGGGTAAATGGCACGGAGA TGTTGCAGTAAAGATCCTAAAGGTTGTCGACCCAACCCCAGAGCAATTCCAGGCCTTCAGGAATGAGGTGGCTGTTCTGCGCAAAACACG GCATGTGAACATTCTGCTTTTCATGGGGTACATGACAAAGGACAACCTGGCAATTGTGACCCAGTGGTGCGAGGGCAGCAGCCTCTACAA ACACCTGCATGTCCAGGAGACCAAGTTTCAGATGTTCCAGCTAATTGACATTGCCCGGCAGACGGCTCAGGGAATGGACTATTTGCATGC AAAGAACATCATCCATAGAGACATGAAATCCAACAATATATTTCTCCATGAAGGCTTAACAGTGAAAATTGGAGATTTTGGTTTGGCAAC AGTAAAGTCACGCTGGAGTGGTTCTCAGCAGGTTGAACAACCTACTGGCTCTGTCCTCTGGATGGCCCCAGAGGTGATCCGAATGCAGGA TAACAACCCATTCAGTTTCCAGTCGGATGTCTACTCCTATGGCATCGTATTGTATGAACTGATGACGGGGGAGCTTCCTTATTCTCACAT CAACAACCGAGATCAGATCATCTTCATGGTGGGCCGAGGATATGCCTCCCCAGATCTTAGTAAGCTATATAAGAACTGCCCCAAAGCAAT GAAGAGGCTGGTAGCTGACTGTGTGAAGAAAGTAAAGGAAGAGAGGCCTCTTTTTCCCCAGATCCTGTCTTCCATTGAGCTGCTCCAACA CTCTCTACCGAAGATCAACCGGAGCGCTTCCGAGCCATCCTTGCATCGGGCAGCCCACACTGAGGATATCAATGCTTGCACGCTGACCAC GTCCCCGAGGCTGCCTGTCTTCTAGTTGACTTTGCACCTGTCTTCAGGCTGCCAGGGGAGGAGGAGAAGCCAGCAGGCACCACTTTTCTG CTCCCTTTCTCCAGAGGCAGAACACATGTTTTCAGAGAAGCTGCTGCTAAGGACCTTCTAGACTGCTCACAGGGCCTTAACTTCATGTTG CCTTCTTTTCTATCCCTTTGGGCCCTGGGAGAAGGAAGCCATTTGCAGTGCTGGTGTGTCCTGCTCCCTCCCCACATTCCCCATGCTCAA GGCCCAGCCTTCTGTAGATGCGCAAGTGGATGTTGATGGTAGTACAAAAAGCAGGGGCCCAGCCCCAGCTGTTGGCTACATGAGTATTTA GAGGAAGTAAGGTAGCAGGCAGTCCAGCCCTGATGTGGAGACACATGGGATTTTGGAAATCAGCTTCTGGAGGAATGCATGTCACAGGCG GGACTTTCTTCAGAGAGTGGTGCAGCGCCAGACATTTTGCACATAAGGCACCAAACAGCCCAGGACTGCCGAGACTCTGGCCGCCCGAAG GAGCCTGCTTTGGTACTATGGAACTTTTCTTAGGGGACACGTCCTCCTTTCACAGCTTCTAAGGTGTCCAGTGCATTGGGATGGTTTTCC AGGCAAGGCACTCGGCCAATCCGCATCTCAGCCCTCTCAGGGAGCAGTCTTCCATCATGCTGAATTTTGTCTTCCAGGAGCTGCCCCTAT GGGGCGGGGCCGCAGGGCCAGCCTTGTTTCTCTAACAAACAAACAAACAAACAGCCTTGTTTCTCTAGTCACATCATGTGTATACAAGGA AGCCAGGAATACAGGTTTTCTTGATGATTTGGGTTTTAATTTTGTTTTTATTGCACCTGACAAAATACAGTTATCTGATGGTCCCTCAAT TATGTTATTTTAATAAAATAAATTAAATTTAGGTGTAA >2882_2882_1_AGGF1-RAF1_AGGF1_chr5_76335544_ENST00000312916_RAF1_chr3_12641914_ENST00000251849_length(amino acids)=692AA_BP=322 MPARSSGLWVRRRPFRPERSPSAATSSLAPELMASEAPSPPRSPPPPTSPEPELAQLRRKVEKLERELRSCKRQVREIEKLLHHTERLYQ NAESNNQELRTQVEELSKILQRGRNEDNKKSDVEVQTENHAPWSISDYFYQTYYNDVSLPNKVTELSDQQDQAIETSILNSKDHLQVEND AYPGTDRTENVKYRQVDHFASNSQEPASALATEDTSLEGSSLAESLRAAAEAAVSQTGFSYDENTGLYFDHSTGFYYDSENQLYYDPSTG IYYYCDVESGRYQFHSRVDLQPYPTSSTKQSKDKKLKKKRKDPDSSATNEEKDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQR ERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVA DCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF -------------------------------------------------------------- >2882_2882_2_AGGF1-RAF1_AGGF1_chr5_76335544_ENST00000312916_RAF1_chr3_12641914_ENST00000442415_length(transcript)=3081nt_BP=1252nt GGTCCCGCCTGCCGCTGGCGCCGTTGTTTCCGGCTCAACTGGGGAGCTGCTGGAGCTCTTCTGGCCTCTGGTTTTCCGACTGCTTATCCG ACGCTCCTCCCTCTGTCTCTGTAGCTGGAGAAGGTAGTTTCCAGGAAAGTTTTCCGGTTTGCAGGCCGCGCACATCGGGCAGGGGCCATC CTCGGTCCCCTTGCTCGTTGCTCGCAGCCCCGTTCGGCTACAAGTGAGTTTCAGGGCGTCATGGCCAGGGGCCACCGCGGCCAGCCGGGT GTGAGGCTGCCTTTCGCTGCCCGCGCGCTCCAGTGGTCTCTGGGTCCGCCGGCGTCCGTTTCGGCCTGAACGCAGCCCCTCCGCGGCGAC GAGCAGTCTCGCGCCGGAGCTCATGGCCTCGGAGGCGCCGTCCCCGCCGCGGTCGCCGCCGCCGCCCACCTCCCCCGAGCCTGAGCTGGC CCAGCTAAGGCGGAAGGTGGAGAAGTTGGAACGTGAACTGCGGAGCTGCAAGCGGCAGGTGCGGGAGATCGAGAAGCTGCTGCATCACAC AGAACGGCTGTACCAGAACGCAGAAAGCAACAACCAGGAGCTCCGCACGCAGGTGGAAGAACTCAGTAAAATACTCCAACGTGGGAGAAA TGAAGATAATAAAAAGTCTGATGTAGAAGTACAAACAGAGAACCATGCTCCTTGGTCAATCTCAGATTATTTTTATCAGACGTACTACAA TGACGTTAGTCTTCCAAATAAAGTGACTGAACTGTCAGATCAACAAGATCAAGCTATCGAAACTTCTATTTTGAATTCTAAAGACCATTT ACAAGTAGAAAATGATGCTTACCCTGGTACCGATAGAACAGAAAATGTTAAATATAGACAAGTGGACCATTTTGCCTCAAATTCACAGGA GCCAGCATCTGCATTAGCAACAGAAGATACCTCCTTAGAAGGCTCATCATTAGCTGAAAGTTTGAGAGCTGCAGCAGAAGCGGCTGTATC ACAGACTGGATTTAGTTATGATGAAAATACTGGACTGTATTTTGACCACAGCACTGGTTTCTATTATGATTCTGAAAATCAACTCTATTA TGATCCTTCCACTGGAATTTATTACTATTGTGATGTGGAAAGTGGTCGTTATCAGTTTCATTCTCGAGTAGATTTGCAACCTTATCCGAC TTCTAGCACAAAACAAAGTAAAGATAAAAAATTGAAGAAGAAAAGAAAAGATCCAGATTCTTCTGCAACAAATGAGGAAAAGGATGCAAT TCGAAGTCACAGCGAATCAGCCTCACCTTCAGCCCTGTCCAGTAGCCCCAACAATCTGAGCCCAACAGGCTGGTCACAGCCGAAAACCCC CGTGCCAGCACAAAGAGAGCGGGCACCAGTATCTGGGACCCAGGAGAAAAACAAAATTAGGCCTCGTGGACAGAGAGATTCAAGCTATTA TTGGGAAATAGAAGCCAGTGAAGTGATGCTGTCCACTCGGATTGGGTCAGGCTCTTTTGGAACTGTTTATAAGGGTAAATGGCACGGAGA TGTTGCAGTAAAGATCCTAAAGGTTGTCGACCCAACCCCAGAGCAATTCCAGGCCTTCAGGAATGAGGTGGCTGTTCTGCGCAAAACACG GCATGTGAACATTCTGCTTTTCATGGGGTACATGACAAAGGACAACCTGGCAATTGTGACCCAGTGGTGCGAGGGCAGCAGCCTCTACAA ACACCTGCATGTCCAGGAGACCAAGTTTCAGATGTTCCAGCTAATTGACATTGCCCGGCAGACGGCTCAGGGAATGGACTATTTGCATGC AAAGAACATCATCCATAGAGACATGAAATCCAACAATATATTTCTCCATGAAGGCTTAACAGTGAAAATTGGAGATTTTGGTTTGGCAAC AGTAAAGTCACGCTGGAGTGGTTCTCAGCAGGTTGAACAACCTACTGGCTCTGTCCTCTGGATGGCCCCAGAGGTGATCCGAATGCAGGA TAACAACCCATTCAGTTTCCAGTCGGATGTCTACTCCTATGGCATCGTATTGTATGAACTGATGACGGGGGAGCTTCCTTATTCTCACAT CAACAACCGAGATCAGATCATCTTCATGGTGGGCCGAGGATATGCCTCCCCAGATCTTAGTAAGCTATATAAGAACTGCCCCAAAGCAAT GAAGAGGCTGGTAGCTGACTGTGTGAAGAAAGTAAAGGAAGAGAGGCCTCTTTTTCCCCAGATCCTGTCTTCCATTGAGCTGCTCCAACA CTCTCTACCGAAGATCAACCGGAGCGCTTCCGAGCCATCCTTGCATCGGGCAGCCCACACTGAGGATATCAATGCTTGCACGCTGACCAC GTCCCCGAGGCTGCCTGTCTTCTAGTTGACTTTGCACCTGTCTTCAGGCTGCCAGGGGAGGAGGAGAAGCCAGCAGGCACCACTTTTCTG CTCCCTTTCTCCAGAGGCAGAACACATGTTTTCAGAGAAGCTGCTGCTAAGGACCTTCTAGACTGCTCACAGGGCCTTAACTTCATGTTG CCTTCTTTTCTATCCCTTTGGGCCCTGGGAGAAGGAAGCCATTTGCAGTGCTGGTGTGTCCTGCTCCCTCCCCACATTCCCCATGCTCAA GGCCCAGCCTTCTGTAGATGCGCAAGTGGATGTTGATGGTAGTACAAAAAGCAGGGGCCCAGCCCCAGCTGTTGGCTACATGAGTATTTA GAGGAAGTAAGGTAGCAGGCAGTCCAGCCCTGATGTGGAGACACATGGGATTTTGGAAATCAGCTTCTGGAGGAATGCATGTCACAGGCG GGACTTTCTTCAGAGAGTGGTGCAGCGCCAGACATTTTGCACATAAGGCACCAAACAGCCCAGGACTGCCGAGACTCTGGCCGCCCGAAG GAGCCTGCTTTGGTACTATGGAACTTTTCTTAGGGGACACGTCCTCCTTTCACAGCTTCTAAGGTGTCCAGTGCATTGGGATGGTTTTCC AGGCAAGGCACTCGGCCAATCCGCATCTCAGCCCTCTCAGGGAGCAGTCTTCCATCATGCTGAATTTTGTCTTCCAGGAGCTGCCCCTAT GGGGCGGGGCCGCAGGGCCAG >2882_2882_2_AGGF1-RAF1_AGGF1_chr5_76335544_ENST00000312916_RAF1_chr3_12641914_ENST00000442415_length(amino acids)=692AA_BP=322 MPARSSGLWVRRRPFRPERSPSAATSSLAPELMASEAPSPPRSPPPPTSPEPELAQLRRKVEKLERELRSCKRQVREIEKLLHHTERLYQ NAESNNQELRTQVEELSKILQRGRNEDNKKSDVEVQTENHAPWSISDYFYQTYYNDVSLPNKVTELSDQQDQAIETSILNSKDHLQVEND AYPGTDRTENVKYRQVDHFASNSQEPASALATEDTSLEGSSLAESLRAAAEAAVSQTGFSYDENTGLYFDHSTGFYYDSENQLYYDPSTG IYYYCDVESGRYQFHSRVDLQPYPTSSTKQSKDKKLKKKRKDPDSSATNEEKDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQR ERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVA DCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF -------------------------------------------------------------- >2882_2882_3_AGGF1-RAF1_AGGF1_chr5_76335544_ENST00000312916_RAF1_chr3_12641914_ENST00000534997_length(transcript)=2612nt_BP=1252nt GGTCCCGCCTGCCGCTGGCGCCGTTGTTTCCGGCTCAACTGGGGAGCTGCTGGAGCTCTTCTGGCCTCTGGTTTTCCGACTGCTTATCCG ACGCTCCTCCCTCTGTCTCTGTAGCTGGAGAAGGTAGTTTCCAGGAAAGTTTTCCGGTTTGCAGGCCGCGCACATCGGGCAGGGGCCATC CTCGGTCCCCTTGCTCGTTGCTCGCAGCCCCGTTCGGCTACAAGTGAGTTTCAGGGCGTCATGGCCAGGGGCCACCGCGGCCAGCCGGGT GTGAGGCTGCCTTTCGCTGCCCGCGCGCTCCAGTGGTCTCTGGGTCCGCCGGCGTCCGTTTCGGCCTGAACGCAGCCCCTCCGCGGCGAC GAGCAGTCTCGCGCCGGAGCTCATGGCCTCGGAGGCGCCGTCCCCGCCGCGGTCGCCGCCGCCGCCCACCTCCCCCGAGCCTGAGCTGGC CCAGCTAAGGCGGAAGGTGGAGAAGTTGGAACGTGAACTGCGGAGCTGCAAGCGGCAGGTGCGGGAGATCGAGAAGCTGCTGCATCACAC AGAACGGCTGTACCAGAACGCAGAAAGCAACAACCAGGAGCTCCGCACGCAGGTGGAAGAACTCAGTAAAATACTCCAACGTGGGAGAAA TGAAGATAATAAAAAGTCTGATGTAGAAGTACAAACAGAGAACCATGCTCCTTGGTCAATCTCAGATTATTTTTATCAGACGTACTACAA TGACGTTAGTCTTCCAAATAAAGTGACTGAACTGTCAGATCAACAAGATCAAGCTATCGAAACTTCTATTTTGAATTCTAAAGACCATTT ACAAGTAGAAAATGATGCTTACCCTGGTACCGATAGAACAGAAAATGTTAAATATAGACAAGTGGACCATTTTGCCTCAAATTCACAGGA GCCAGCATCTGCATTAGCAACAGAAGATACCTCCTTAGAAGGCTCATCATTAGCTGAAAGTTTGAGAGCTGCAGCAGAAGCGGCTGTATC ACAGACTGGATTTAGTTATGATGAAAATACTGGACTGTATTTTGACCACAGCACTGGTTTCTATTATGATTCTGAAAATCAACTCTATTA TGATCCTTCCACTGGAATTTATTACTATTGTGATGTGGAAAGTGGTCGTTATCAGTTTCATTCTCGAGTAGATTTGCAACCTTATCCGAC TTCTAGCACAAAACAAAGTAAAGATAAAAAATTGAAGAAGAAAAGAAAAGATCCAGATTCTTCTGCAACAAATGAGGAAAAGGATGCAAT TCGAAGTCACAGCGAATCAGCCTCACCTTCAGCCCTGTCCAGTAGCCCCAACAATCTGAGCCCAACAGGCTGGTCACAGCCGAAAACCCC CGTGCCAGCACAAAGAGAGCGGGCACCAGTATCTGGGACCCAGGAGAAAAACAAAATTAGGCCTCGTGGACAGAGAGATTCAAGCTATTA TTGGGAAATAGAAGCCAGTGAAGTGATGCTGTCCACTCGGATTGGGTCAGGCTCTTTTGGAACTGTTTATAAGGGTAAATGGCACGGAGA TGTTGCAGTAAAGATCCTAAAGGTTGTCGACCCAACCCCAGAGCAATTCCAGGCCTTCAGGAATGAGGTGGCTGTTCTGCGCAAAACACG GCATGTGAACATTCTGCTTTTCATGGGGTACATGACAAAGGACAACCTGGCAATTGTGACCCAGTGGTGCGAGGGCAGCAGCCTCTACAA ACACCTGCATGTCCAGGAGACCAAGTTTCAGATGTTCCAGCTAATTGACATTGCCCGGCAGACGGCTCAGGGAATGGACTATTTGCATGC AAAGAACATCATCCATAGAGACATGAAATCCAACAATATATTTCTCCATGAAGGCTTAACAGTGAAAATTGGAGATTTTGGTTTGGCAAC AGTAAAGTCACGCTGGAGTGGTTCTCAGCAGGTTGAACAACCTACTGGCTCTGTCCTCTGGATGGCCCCAGAGGTGATCCGAATGCAGGA TAACAACCCATTCAGTTTCCAGTCGGATGTCTACTCCTATGGCATCGTATTGTATGAACTGATGACGGGGGAGCTTCCTTATTCTCACAT CAACAACCGAGATCAGATCATCTTCATGGTGGGCCGAGGATATGCCTCCCCAGATCTTAGTAAGCTATATAAGAACTGCCCCAAAGCAAT GAAGAGGCTGGTAGCTGACTGTGTGAAGAAAGTAAAGGAAGAGAGGCCTCTTTTTCCCCAGATCCTGTCTTCCATTGAGCTGCTCCAACA CTCTCTACCGAAGATCAACCGGAGCGCTTCCGAGCCATCCTTGCATCGGGCAGCCCACACTGAGGATATCAATGCTTGCACGCTGACCAC GTCCCCGAGGCTGCCTGTCTTCTAGTTGACTTTGCACCTGTCTTCAGGCTGCCAGGGGAGGAGGAGAAGCCAGCAGGCACCACTTTTCTG CTCCCTTTCTCCAGAGGCAGAACACATGTTTTCAGAGAAGCTGCTGCTAAGGACCTTCTAGACTGCTCACAGGGCCTTAACTTCATGTTG CCTTCTTTTCTATCCCTTTGGGCCCTGGGAGAAGGAAGCCATTTGCAGTGCTGGTGTGTCCTGCTCCCTCCCCACATTCCCCATGCTCAA GG >2882_2882_3_AGGF1-RAF1_AGGF1_chr5_76335544_ENST00000312916_RAF1_chr3_12641914_ENST00000534997_length(amino acids)=692AA_BP=322 MPARSSGLWVRRRPFRPERSPSAATSSLAPELMASEAPSPPRSPPPPTSPEPELAQLRRKVEKLERELRSCKRQVREIEKLLHHTERLYQ NAESNNQELRTQVEELSKILQRGRNEDNKKSDVEVQTENHAPWSISDYFYQTYYNDVSLPNKVTELSDQQDQAIETSILNSKDHLQVEND AYPGTDRTENVKYRQVDHFASNSQEPASALATEDTSLEGSSLAESLRAAAEAAVSQTGFSYDENTGLYFDHSTGFYYDSENQLYYDPSTG IYYYCDVESGRYQFHSRVDLQPYPTSSTKQSKDKKLKKKRKDPDSSATNEEKDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQR ERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVA DCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF -------------------------------------------------------------- >2882_2882_4_AGGF1-RAF1_AGGF1_chr5_76335544_ENST00000312916_RAF1_chr3_12641914_ENST00000542177_length(transcript)=2546nt_BP=1252nt GGTCCCGCCTGCCGCTGGCGCCGTTGTTTCCGGCTCAACTGGGGAGCTGCTGGAGCTCTTCTGGCCTCTGGTTTTCCGACTGCTTATCCG ACGCTCCTCCCTCTGTCTCTGTAGCTGGAGAAGGTAGTTTCCAGGAAAGTTTTCCGGTTTGCAGGCCGCGCACATCGGGCAGGGGCCATC CTCGGTCCCCTTGCTCGTTGCTCGCAGCCCCGTTCGGCTACAAGTGAGTTTCAGGGCGTCATGGCCAGGGGCCACCGCGGCCAGCCGGGT GTGAGGCTGCCTTTCGCTGCCCGCGCGCTCCAGTGGTCTCTGGGTCCGCCGGCGTCCGTTTCGGCCTGAACGCAGCCCCTCCGCGGCGAC GAGCAGTCTCGCGCCGGAGCTCATGGCCTCGGAGGCGCCGTCCCCGCCGCGGTCGCCGCCGCCGCCCACCTCCCCCGAGCCTGAGCTGGC CCAGCTAAGGCGGAAGGTGGAGAAGTTGGAACGTGAACTGCGGAGCTGCAAGCGGCAGGTGCGGGAGATCGAGAAGCTGCTGCATCACAC AGAACGGCTGTACCAGAACGCAGAAAGCAACAACCAGGAGCTCCGCACGCAGGTGGAAGAACTCAGTAAAATACTCCAACGTGGGAGAAA TGAAGATAATAAAAAGTCTGATGTAGAAGTACAAACAGAGAACCATGCTCCTTGGTCAATCTCAGATTATTTTTATCAGACGTACTACAA TGACGTTAGTCTTCCAAATAAAGTGACTGAACTGTCAGATCAACAAGATCAAGCTATCGAAACTTCTATTTTGAATTCTAAAGACCATTT ACAAGTAGAAAATGATGCTTACCCTGGTACCGATAGAACAGAAAATGTTAAATATAGACAAGTGGACCATTTTGCCTCAAATTCACAGGA GCCAGCATCTGCATTAGCAACAGAAGATACCTCCTTAGAAGGCTCATCATTAGCTGAAAGTTTGAGAGCTGCAGCAGAAGCGGCTGTATC ACAGACTGGATTTAGTTATGATGAAAATACTGGACTGTATTTTGACCACAGCACTGGTTTCTATTATGATTCTGAAAATCAACTCTATTA TGATCCTTCCACTGGAATTTATTACTATTGTGATGTGGAAAGTGGTCGTTATCAGTTTCATTCTCGAGTAGATTTGCAACCTTATCCGAC TTCTAGCACAAAACAAAGTAAAGATAAAAAATTGAAGAAGAAAAGAAAAGATCCAGATTCTTCTGCAACAAATGAGGAAAAGGATGCAAT TCGAAGTCACAGCGAATCAGCCTCACCTTCAGCCCTGTCCAGTAGCCCCAACAATCTGAGCCCAACAGGCTGGTCACAGCCGAAAACCCC CGTGCCAGCACAAAGAGAGCGGGCACCAGTATCTGGGACCCAGGAGAAAAACAAAATTAGGCCTCGTGGACAGAGAGATTCAAGCTATTA TTGGGAAATAGAAGCCAGTGAAGTGATGCTGTCCACTCGGATTGGGTCAGGCTCTTTTGGAACTGTTTATAAGGGTAAATGGCACGGAGA TGTTGCAGTAAAGATCCTAAAGGTTGTCGACCCAACCCCAGAGCAATTCCAGGCCTTCAGGAATGAGGTGGCTGTTCTGCGCAAAACACG GCATGTGAACATTCTGCTTTTCATGGGGTACATGACAAAGGACAACCTGGCAATTGTGACCCAGTGGTGCGAGGGCAGCAGCCTCTACAA ACACCTGCATGTCCAGGAGACCAAGTTTCAGATGTTCCAGCTAATTGACATTGCCCGGCAGACGGCTCAGGGAATGGACTATTTGCATGC AAAGAACATCATCCATAGAGACATGAAATCCAACAATATATTTCTCCATGAAGGCTTAACAGTGAAAATTGGAGATTTTGGTTTGGCAAC AGTAAAGTCACGCTGGAGTGGTTCTCAGCAGGTTGAACAACCTACTGGCTCTGTCCTCTGGATGGCCCCAGAGGTGATCCGAATGCAGGA TAACAACCCATTCAGTTTCCAGTCGGATGTCTACTCCTATGGCATCGTATTGTATGAACTGATGACGGGGGAGCTTCCTTATTCTCACAT CAACAACCGAGATCAGATCATCTTCATGGTGGGCCGAGGATATGCCTCCCCAGATCTTAGTAAGCTATATAAGAACTGCCCCAAAGCAAT GAAGAGGCTGGTAGCTGACTGTGTGAAGAAAGTAAAGGAAGAGAGGCCTCTTTTTCCCCAGATCCTGTCTTCCATTGAGCTGCTCCAACA CTCTCTACCGAAGATCAACCGGAGCGCTTCCGAGCCATCCTTGCATCGGGCAGCCCACACTGAGGATATCAATGCTTGCACGCTGACCAC GTCCCCGAGGCTGCCTGTCTTCTAGTTGACTTTGCACCTGTCTTCAGGCTGCCAGGGGAGGAGGAGAAGCCAGCAGGCACCACTTTTCTG CTCCCTTTCTCCAGAGGCAGAACACATGTTTTCAGAGAAGCTGCTGCTAAGGACCTTCTAGACTGCTCACAGGGCCTTAACTTCATGTTG CCTTCTTTTCTATCCCTTTGGGCCCT >2882_2882_4_AGGF1-RAF1_AGGF1_chr5_76335544_ENST00000312916_RAF1_chr3_12641914_ENST00000542177_length(amino acids)=692AA_BP=322 MPARSSGLWVRRRPFRPERSPSAATSSLAPELMASEAPSPPRSPPPPTSPEPELAQLRRKVEKLERELRSCKRQVREIEKLLHHTERLYQ NAESNNQELRTQVEELSKILQRGRNEDNKKSDVEVQTENHAPWSISDYFYQTYYNDVSLPNKVTELSDQQDQAIETSILNSKDHLQVEND AYPGTDRTENVKYRQVDHFASNSQEPASALATEDTSLEGSSLAESLRAAAEAAVSQTGFSYDENTGLYFDHSTGFYYDSENQLYYDPSTG IYYYCDVESGRYQFHSRVDLQPYPTSSTKQSKDKKLKKKRKDPDSSATNEEKDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQR ERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVA DCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for AGGF1-RAF1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Tgene | RAF1 | chr5:76335544 | chr3:12641914 | ENST00000251849 | 6 | 17 | 331_349 | 278.0 | 649.0 | PEBP1/RKIP | |
Tgene | RAF1 | chr5:76335544 | chr3:12641914 | ENST00000442415 | 7 | 18 | 331_349 | 298.0 | 669.0 | PEBP1/RKIP |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for AGGF1-RAF1 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | RAF1 | P04049 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
Tgene | RAF1 | P04049 | DB08896 | Regorafenib | Inhibitor | Small molecule | Approved |
Tgene | RAF1 | P04049 | DB00398 | Sorafenib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | RAF1 | P04049 | DB00398 | Sorafenib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | RAF1 | P04049 | DB08862 | Cholecystokinin | Agonist | Small molecule | Approved|Investigational |
Tgene | RAF1 | P04049 | DB08862 | Cholecystokinin | Agonist | Small molecule | Approved|Investigational |
Tgene | RAF1 | P04049 | DB08912 | Dabrafenib | Antagonist|Inhibitor | Small molecule | Approved|Investigational |
Tgene | RAF1 | P04049 | DB08912 | Dabrafenib | Antagonist|Inhibitor | Small molecule | Approved|Investigational |
Tgene | RAF1 | P04049 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Tgene | RAF1 | P04049 | DB12010 | Fostamatinib | Inhibitor | Small molecule | Approved|Investigational |
Top |
Related Diseases for AGGF1-RAF1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | AGGF1 | C0022739 | Klippel-Trenaunay-Weber Syndrome | 2 | ORPHANET;UNIPROT |
Tgene | C0028326 | Noonan Syndrome | 10 | CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET | |
Tgene | C0175704 | LEOPARD Syndrome | 7 | CLINGEN;CTD_human;GENOMICS_ENGLAND | |
Tgene | C1969057 | Noonan Syndrome 5 | 4 | CTD_human;GENOMICS_ENGLAND;UNIPROT | |
Tgene | C1969056 | LEOPARD SYNDROME 2 | 3 | CTD_human;GENOMICS_ENGLAND;UNIPROT | |
Tgene | C0007194 | Hypertrophic Cardiomyopathy | 2 | CTD_human | |
Tgene | C0041409 | Turner Syndrome, Male | 2 | CTD_human | |
Tgene | C1519086 | Pilomyxoid astrocytoma | 2 | ORPHANET | |
Tgene | C1527404 | Female Pseudo-Turner Syndrome | 2 | CTD_human | |
Tgene | C4551472 | Hypertrophic obstructive cardiomyopathy | 2 | CTD_human | |
Tgene | C4551602 | Noonan Syndrome 1 | 2 | CTD_human | |
Tgene | C0006142 | Malignant neoplasm of breast | 1 | CTD_human | |
Tgene | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human | |
Tgene | C0007193 | Cardiomyopathy, Dilated | 1 | CTD_human | |
Tgene | C0017638 | Glioma | 1 | CTD_human | |
Tgene | C0020429 | Hyperalgesia | 1 | CTD_human | |
Tgene | C0022665 | Kidney Neoplasm | 1 | CTD_human | |
Tgene | C0023903 | Liver neoplasms | 1 | CTD_human | |
Tgene | C0024121 | Lung Neoplasms | 1 | CTD_human | |
Tgene | C0242379 | Malignant neoplasm of lung | 1 | CTD_human | |
Tgene | C0259783 | mixed gliomas | 1 | CTD_human | |
Tgene | C0340427 | Familial dilated cardiomyopathy | 1 | ORPHANET | |
Tgene | C0345904 | Malignant neoplasm of liver | 1 | CTD_human | |
Tgene | C0345967 | Malignant mesothelioma | 1 | CTD_human | |
Tgene | C0458247 | Allodynia | 1 | CTD_human | |
Tgene | C0555198 | Malignant Glioma | 1 | CTD_human | |
Tgene | C0587248 | Costello syndrome (disorder) | 1 | CLINGEN | |
Tgene | C0678222 | Breast Carcinoma | 1 | CTD_human | |
Tgene | C0740457 | Malignant neoplasm of kidney | 1 | CTD_human | |
Tgene | C0751211 | Hyperalgesia, Primary | 1 | CTD_human | |
Tgene | C0751212 | Hyperalgesia, Secondary | 1 | CTD_human | |
Tgene | C0751213 | Tactile Allodynia | 1 | CTD_human | |
Tgene | C0751214 | Hyperalgesia, Thermal | 1 | CTD_human | |
Tgene | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human | |
Tgene | C1275081 | Cardio-facio-cutaneous syndrome | 1 | CLINGEN | |
Tgene | C1449563 | Cardiomyopathy, Familial Idiopathic | 1 | CTD_human | |
Tgene | C1458155 | Mammary Neoplasms | 1 | CTD_human | |
Tgene | C2936719 | Mechanical Allodynia | 1 | CTD_human | |
Tgene | C4014656 | CARDIOMYOPATHY, DILATED, 1NN | 1 | CTD_human;UNIPROT | |
Tgene | C4551484 | Leopard Syndrome 1 | 1 | CTD_human;GENOMICS_ENGLAND | |
Tgene | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human | |
Tgene | C4721610 | Carcinoma, Ovarian Epithelial | 1 | CTD_human |